Sanity Group Deepens Swiss Footprint With Astrasana Distribution Deal
Sanity Group has announced a new distribution partnership with Swiss cannabis operator Astrasana Holding AG, further expanding its footprint in the closely watched Swiss market.
Sanity Group has announced a new distribution partnership with Swiss cannabis operator Astrasana Holding AG, further expanding its footprint in the closely watched Swiss market.
The Japanese government has released long-awaited guidance on THC limits for CBD products, enabling brands hoping to launch into the market to begin devising their strategies.
Japan has officially launched a public comment period for its landmark cannabis reform bill, offering new details on how its nascent cannabis industry will look over the coming months.
The Czech Republic’s lower house has passed a proposal seeking to regulate ‘psychomodulating’ substances, which is likely to include synthetic cannabinoids such as HHC.
Curaleaf International, part of Curaleaf Holdings (TSX:CURA) and one of Europe’s largest vertically integrated cannabis companies, is expanding into the Czech Republic, a new market for the company, through a new supply agreement with Astrasana Pharma s.r.o.
Astrasana Holding AG is pleased to announce the successful completion of the majority acquisition of Releaf for Pets, marking a significant milestone for Europe’s foremost approved CBD veterinary product line.
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.DE” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Cantourage Group reported its Q3 financial figures this week, celebrating ‘significant revenue growth’ so far in 2023, but slipped back into the red after reporting a positive EBITDA in its interim results in July.
Japan, one of the world’s strictest and most hostile countries in regard to cannabis, recently took a major step towards reform, potentially providing a major boom for the country’s CBD industry and opening the door for the establishment of a medical cannabis and industrial hemp industry in the country.
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis, has signed a long-term supply agreement for medical cannabis with the Swiss cannabis company Astrasana.